CTI BioPharma Corp.
CTIC · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $552,577 | $771,840 | $707,695 | $647,918 |
| - Cash | $24,209 | $30,420 | $32,048 | $66,091 |
| + Debt | $48,895 | $49,958 | $49,242 | $49,303 |
| Enterprise Value | $577,263 | $791,378 | $724,889 | $631,130 |
| Revenue | $24,116 | $21,083 | $18,241 | $12,329 |
| % Growth | 14.4% | 15.6% | 48% | – |
| Gross Profit | $22,892 | $19,916 | $17,089 | $11,412 |
| % Margin | 94.9% | 94.5% | 93.7% | 92.6% |
| EBITDA | -$7,846 | -$13,707 | -$11,251 | -$18,101 |
| % Margin | -32.5% | -65% | -61.7% | -146.8% |
| Net Income | -$21,795 | -$16,926 | -$15,628 | -$22,664 |
| % Margin | -90.4% | -80.3% | -85.7% | -183.8% |
| EPS Diluted | -0.17 | -0.13 | -0.13 | -0.21 |
| % Growth | -30.8% | 0% | 38.1% | – |
| Operating Cash Flow | -$31,098 | -$15,510 | -$15,463 | -$20,244 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$31,098 | -$15,510 | -$15,463 | -$20,244 |